Ashmosp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-08-19
Share capital
5,000.00 PLN
Registered address
ul. Józefa Wojtarowicza 42-46/12, 33-100 Tarnów, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 2 of 2 financial statements were filed late (the longest delay 467 days for 2023).

  • 2024not filed
  • 202325/10/2025
  • 202229/05/2024
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2023.

Industry · Manufacture of pharmaceutical preparations221 / 258
Top 86%
Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations283 / 330
Top 86%
Sector · Manufacturing30,888 / 33,747
Top 92%
Voivodeship · Małopolskie39,299 / 46,035
Top 85%
Country · Poland424,959 / 495,867
Top 86%

Results vs industry

Revenue
This companyUSD 4.75kMedianUSD 919.05kAverageUSD 25.83m
Net profit
This companyUSD -5.25kMedianUSD 14.92kAverageUSD 2.77m
Operating costs
This companyUSD 3.19kMedianUSD 873.06kAverageUSD 21.43m
Assets
This companyUSD 15.10kMedianUSD 897.46kAverageUSD 31.52m

Industry

Authorized Representatives

Jarosław Daniel Gondek – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Jarosław Daniel Gondekage 50
49$1,323.6198%
Others
1$27.012%

Beneficial owners

Person

Bank accounts

Was a VAT taxpayer from 2021-10-01 to 2024-06-04.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A.
Fagronsp. z o.o.
Krakowskie Zakłady Zielarskie Herbapol w KrakowieS.A.
F1 PharmaS.A.
Ampliconsp. z o.o.
Xenira Pharmaceuticalssp. z o.o.
Sanford Biotechsp. z o.o.
Cefeasp. z o.o.
Auxilius PharmaS.A.
Zakład Farmaceutyczny Amarasp. j.

FAQ

Last updated: 2026-04-06